Jushi Holdings Inc. (JUSHF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.55. It has a SharesGrow Score of 43/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is JUSHF = $2 (+250.9% upside).
Financials: revenue is $263M, -2.5%/yr average growth. Net income is $69M (loss), growing at +17.4%/yr. Net profit margin is -26.1% (negative). Gross margin is 43.4% (+9.8 pp trend).
Balance sheet: total debt is $71M with negative equity of -$115M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 1.03 (adequate). Debt-to-assets is 16.9%. Total assets: $422M.
Analyst outlook: 1 / 2 analysts rate JUSHF as buy (50%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 48/100 (Partial), Past 0/100 (Fail), Health 25/100 (Fail), Moat 51/100 (Partial), Future 64/100 (Pass), Income 10/100 (Fail).
